Chemoinformaics analysis of 5-Hydroxy-6-methoxy-2-methyl-3-phenylbenzofuran
| Molecular Weight | 254.285 | nRot | 2 |
| Heavy Atom Molecular Weight | 240.173 | nRig | 16 |
| Exact Molecular Weight | 254.094 | nRing | 3 |
| Solubility: LogS | -5.129 | nHRing | 1 |
| Solubility: LogP | 3.89 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 15 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 16 |
| nHA | 3 | APOL | 38.4611 |
| nHD | 1 | BPOL | 17.5169 |
| QED | 0.748 |
| Synth | 2.008 |
| Natural Product Likeliness | 0.43 |
| NR-PPAR-gamma | 0.81 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.264 |
| HIA | 0.004 |
| CACO-2 | -4.799 |
| MDCK | 0.0000275 |
| BBB | 0.135 |
| PPB | 0.97944 |
| VDSS | 0.645 |
| FU | 0.021859 |
| CYP1A2-inh | 0.981 |
| CYP1A2-sub | 0.929 |
| CYP2c19-inh | 0.916 |
| CYP2c19-sub | 0.152 |
| CYP2c9-inh | 0.65 |
| CYP2c9-sub | 0.91 |
| CYP2d6-inh | 0.869 |
| CYP2d6-sub | 0.917 |
| CYP3a4-inh | 0.692 |
| CYP3a4-sub | 0.503 |
| CL | 8.996 |
| T12 | 0.389 |
| hERG | 0.048 |
| Ames | 0.657 |
| ROA | 0.135 |
| SkinSen | 0.442 |
| Carcinogencity | 0.38 |
| EI | 0.9 |
| Respiratory | 0.426 |
| NR-Aromatase | 0.899 |
| Antiviral | Yes |
| Prediction | 0.764874 |